| Product Information |
|
| Registration Number |
BR-901
|
| Generic Name |
Trivalent Seasonal Influenza Vaccine (Surface Antigen, Inactivated) 2024 Southern Hemisphere Strain
|
| Brand Name |
Influvac
|
| Dosage Strength |
Each dose (0.5 mL) contains the following strains*:
A/Victoria/4897/2022 (H1N1)pdm09-like strain
15 ug HA**
(A/Victoria/4897/2022, IVR-238)
A/Thailand/8/2022 (H3N2)-like strain
15 ug HA**
(A/Thailand/8/2022, IVR-237)
B/Austria/1359417/2021-like strain
15 ug HA**
(B/Austria/1359417/2021, BVR-26)
*Propagated in embryonated chicken eggs **Haemagglutinin
|
| Dosage Form |
Suspension for Injection (IM/SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
0.5 mL in 1 mL Type I pre-filled glass syringe with grey
bromobutyl rubber plunger with needle (Box of 1's).
|
| Pharmacologic Category |
Vaccines
|
| Manufacturer |
Abbott Biologicals B.V.
|
| Country of Origin |
Netherlands
|
| Trader |
|
| Importer |
Abbott Laboratories
|
| Distributor |
Abbott Laboratories
|
| Application Type |
Monitored Release (Strain Clearance)
|
| Issuance Date |
14 February 2024
|
| Expiry Date |
14 February 2025
|